ADIAL PHARMACEUTICALS, INC.

ADIL · Nasdaq · SIC 2834: Pharmaceutical Preparations
230
SEC Filings

Business Summary

PART I . Overview We are a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Our investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder (AUD). AD04 was investigated in a Phase 3 clinical trial, designated the ONWARD trial, for the potential treatment of AUD in subjects with certain target genotypes, which were identified usin...

Next Earnings

Q2 FY2026 — expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionADILdiscussed_in_filing Artificial Intelligence
topic_mentionADILdiscussed_in_filing Cybersecurity
topic_mentionADILdiscussed_in_filing Trusted Computing
topic_mentionADILdiscussed_in_filing Blockchain & Crypto
topic_mentionADILdiscussed_in_filing Regulation
topic_mentionADILdiscussed_in_filing Healthcare & Bio
topic_mentionADILdiscussed_in_filing Platform & Ecosystem
topic_mentionADILdiscussed_in_filing Sovereign & Government
topic_mentionADILdiscussed_in_filing Artificial Intelligence
topic_mentionADILdiscussed_in_filing Cybersecurity
topic_mentionADILdiscussed_in_filing Trusted Computing
topic_mentionADILdiscussed_in_filing Blockchain & Crypto
topic_mentionADILdiscussed_in_filing Regulation
topic_mentionADILdiscussed_in_filing Healthcare & Bio
topic_mentionADILdiscussed_in_filing Platform & Ecosystem
topic_mentionADILdiscussed_in_filing Sovereign & Government
topic_mentionADILdiscussed_in_filing Artificial Intelligence
topic_mentionADILdiscussed_in_filing Cybersecurity
topic_mentionADILdiscussed_in_filing Trusted Computing
topic_mentionADILdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001213900-26-024175EDGAR87K words
2025-03-042024-12-310001213900-25-019771EDGAR
2024-04-012023-12-310001213900-24-028701EDGAR
2023-03-302022-12-310001213900-23-024719EDGAR
2022-03-282021-12-310001213900-22-015562EDGAR
2021-03-222020-12-310001213900-21-017009EDGAR
2020-03-202019-12-310001213900-20-007020EDGAR
2019-02-192018-12-310001213900-19-002769EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001213900-25-109979EDGAR21K words
2025-08-132025-06-300001213900-25-075695EDGAR
2025-05-142025-03-310001213900-25-043281EDGAR
2024-11-132024-09-300001213900-24-097519EDGAR
2024-08-132024-06-300001213900-24-068262EDGAR
2024-05-142024-03-310001213900-24-043023EDGAR
2023-11-142023-09-300001213900-23-086913EDGAR
2023-08-212023-06-300001213900-23-069141EDGAR
2023-05-122023-03-310001213900-23-038985EDGAR
2022-11-142022-09-300001213900-22-071643EDGAR
2022-08-152022-06-300001213900-22-047638EDGAR
2022-05-162022-03-310001213900-22-026590EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-060001213900-26-024336EDGAR2K words
2026-03-030001213900-26-022718EDGAR
2026-02-240001213900-26-019639EDGAR
2026-02-040001213900-26-012274EDGAR
2026-01-060001213900-26-001790EDGAR
2025-12-010001213900-25-116666EDGAR
2025-11-140001213900-25-110385EDGAR
2025-09-160001213900-25-087925EDGAR
2025-09-030001213900-25-083719EDGAR
2025-08-140001213900-25-076085EDGAR

230 total filings indexed. 200 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA AEON — AEON Biopharma, Inc.

Company Identity

CIK0001513525
TickerADIL
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b5a0bbf91fd610c2be1a09efe3bcc780f7256eafea8743ff07bdb641ba7053ae
parent: ee6f577652957e0479fbb03ed6a64d2ead9e556952dd56c6fe81cd0cabe6652a
content hash: 8729d2c7c6e007046a550a1d6ccb24a77f5adf1e8c5990c82eaadb03d2412f9d
signed: 2026-04-13T04:43:28.077Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf